SL Science Holding Limited Ordinary Shares (NASDAQ:SLBT) — Market Cap & Net Worth
Market Cap & Net Worth: SL Science Holding Limited Ordinary Shares (SLBT)
SL Science Holding Limited Ordinary Shares (NASDAQ:SLBT) has a market capitalization of $2.65 Billion ($2.65 Billion) as of July 13, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #5332 globally and #1744 in its home market, demonstrating a 6.29% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SL Science Holding Limited Ordinary Shares's stock price $4.73 by its total outstanding shares 560759757 (560.76 Million). See SL Science Holding Limited Ordinary Shar capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
SL Science Holding Limited Ordinary Shares Market Cap History: 2026 to 2026
SL Science Holding Limited Ordinary Shares's market capitalization history from 2026 to 2026. Data shows growth from $2.65 Billion to $2.65 Billion (0.00% CAGR).
SL Science Holding Limited Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SL Science Holding Limited Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SLBT by Market Capitalization
Companies near SL Science Holding Limited Ordinary Shares in the global market cap rankings as of July 13, 2026.
Key companies related to SL Science Holding Limited Ordinary Shares by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #429 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #549 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #567 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $485.39 |
| #429 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $664.52 |
| #549 | Argen-X | BR:ARGX | $49.55 Billion | €763.80 |
| #567 | UCB SA | BR:UCB | $47.34 Billion | €237.10 |
SL Science Holding Limited Ordinary Shares Historical Marketcap From 2026 to 2026
Between 2026 and today, SL Science Holding Limited Ordinary Shares's market cap moved from $2.65 Billion to $ 2.65 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.65 Billion | -- |
End of Day Market Cap According to Different Sources
On Jul 12th, 2026 the market cap of SL Science Holding Limited Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.65 Billion USD |
| MoneyControl | $2.65 Billion USD |
| MarketWatch | $2.65 Billion USD |
| marketcap.company | $2.65 Billion USD |
| Reuters | $2.65 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SL Science Holding Limited Ordinary Shares
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was for… Read more